Michael Charles A. Booth
Keine laufenden Positionen mehr
Karriereverlauf von Michael Charles A. Booth
Ehemalige bekannte Positionen von Michael Charles A. Booth
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| INCYTE CORPORATION | Investor Relations Kontakt | 01.05.2014 | - |
| Corporate Officer/Principal | 01.05.2014 | 01.03.2021 | |
| Canaccord Adams Ltd. | Analyst-Equity | 20.06.2003 | 09.08.2007 |
| ALGETA ASA | Investor Relations Kontakt | 17.10.2011 | - |
| Trout International LLC | Corporate Officer/Principal | 01.01.2007 | - |
Ausbildung von Michael Charles A. Booth
| University of Oxford | Doctorate Degree |
| University of St. Andrews | Undergraduate Degree |
Statistik
International
| Vereinigtes Königreich | 5 |
| Vereinigte Staaten | 2 |
| Norwegen | 2 |
Operativ
| Investor Relations Contact | 2 |
| Corporate Officer/Principal | 2 |
| Analyst-Equity | 1 |
Sektoral
| Health Technology | 3 |
| Consumer Services | 3 |
| Finance | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| INCYTE CORPORATION | Health Technology |
| Private Unternehmen | 3 |
|---|---|
| Canaccord Adams Ltd. | Finance |
| Trout International LLC | |
Algeta ASA
 Algeta ASA Pharmaceuticals: MajorHealth Technology Algeta ASA is engaged in the development of products for the treatment of cancer. The company focuses on the development of anti-cancer drugs, and its research and development of compounds focuses on the various applications of a few base compounds. Its products, Alpharadin and Thorium-227, are being developed for treatment of skeletal metastases originating from prostate and breast cancer. The company was founded by Roy H. Larsen and Øyvind Sverre Bruland in 1997 and is headquartered in Oslo, Norway. | Health Technology |
